[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-337502-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-337502-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","subtype-transdifferentiation-in-human-cancer-tissue-plasticity-and-tumor-progression","Subtype Transdifferentiation in Human Cancer - Tissue Plasticity and Tumor Progression","","Tumor classification into subtypes defined by differentiation pathways supports diagnosis and targeted therapy, yet next-generation sequencing reveals far greater phenotypic heterogeneity than expected. During progression, tumors remain highly dynamic and can modify subtype characteristics, further complicated by treatment-induced responses. Cancer cells can transdifferentiate to adapt to changing microenvironments, altering growth, invasiveness, treatment sensitivity, and clinical behavior. Studying subtype transitions clarifies tumor evolution and enables prediction and personalized therapeutic strategies, with mechanisms discussed across breast cancer, prostate cancer, glioblastoma, and pancreatic adenocarcinoma.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/subtype-transdifferentiation-in-human-cancer-tissue-plasticity-and-tumor-progression/337502/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/subtype-transdifferentiation-in-human-cancer-tissue-plasticity-and-tumor-progression/337502.png","ImageObject",300,407,{"name":42,"@type":43},"Anda","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-02","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",11,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is tumor subtype classification important, and what challenge has emerged with next-generation sequencing?","Question",{"text":63,"@type":64},"Subtype classification links phenotypes to differentiation pathways for diagnosis and targeted therapy. Next-generation sequencing shows cancer phenotypes are more heterogeneous and require continual updates to include additional subtypes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do tumor cells change subtype during disease progression and therapy response?",{"text":68,"@type":64},"Tumors can evolve dynamically and cancer cells may acquire the ability to transdifferentiate, switching subtype and adapting to the tumor microenvironment. These changes influence growth rate, invasiveness, treatment response, and overall clinical behavior.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancers are examined to illustrate tissue plasticity-driven subtype switching?",{"text":72,"@type":64},"The article discusses four human cancers where tissue plasticity can cause a subtype switch: breast cancer, prostate cancer, glioblastoma, and pancreatic adenocarcinoma.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},337502,1790528188,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},962075006959,"https://ap-avatar.wpscdn.com/avatar/e0002397efbe92a78e?_k=1776741047341049297","cells  \nReview  \nSubtype Transdifferentiation in Human Cancer: The Power of Tissue Plasticity in Tumor Progression  \nMonica Fedele *, Laura Cerchia  and Sabrina Battista   \nCitation: Fedele, M.; Cerchia, L.; Battista, S. Subtype Transdifferentiation in Human Cancer:  \nThe Power of Tissue Plasticity in Tumor Progression. Cells 2024, 13, 350 . [https://doi.org/10.3390/cells13040350](https://doi.org/10.3390/cells13040350)  \nAcademic Editor: Jozsef Dudas  \nReceived: 19 January 2024  \nRevised: 8 February 2024  \nAccepted: 15 February 2024  \nPublished: 17 February 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nInstitute of Experimental Endocrinology and Oncology “G. Salvatore”(IEOS), National Research Council—CNR, 80131 Naples, Italy; [cerchia@unina.it](cerchia@unina.it) (L.C.); [sabattis@unina.it](sabattis@unina.it) (S.B.)  \n* Correspondence: mfedele@unina.it or monica.fedele@cnr.it  \nAbstract: The classification of tumors into subtypes, characterized by phenotypes determined by specific differentiation pathways, aids diagnosis and directs therapy towards targeted approaches. However, with the advent and explosion of next-generation sequencing, cancer phenotypes are turning out to be far more heterogenous than initially thought, and the classification is continually being updated to include more subtypes. Tumors are indeed highly dynamic, and they can evolve and undergo various changes in their characteristics during disease progression. The picture becomeseven more complex when the tumor responds to a therapy. In all these cases, cancer cells acquire the ability to transdifferentiate, changing subtype, and adapt to changing microenvironments. These modifications affect the tumor’s growth rate, invasiveness, response to treatment, and overall clinical behavior. Studying tumor subtype transitions is crucial for understanding tumor evolution, predicting disease outcomes, and developing personalized treatment strategies. We discuss this emerging hallmark of cancer and the molecular mechanisms involved at the crossroads between tumor cells and their microenvironment, focusing on four different human cancers in which tissue plasticity causes a subtype switch: breast cancer, prostate cancer, glioblastoma, and pancreatic adenocarcinoma.  \nKeywords: luminal to basal-like transition; neuroendocrine differentiation; proneural to mesenchymal transition; tissue transdifferentiation; breast cancer; prostate cancer; glioblastoma; pancreatic adenocarcinoma  \n1. Introduction  \nDuring development, determination and organization of cells in tissues is accompanied by their terminal differentiation, which locks cells into a specific phenotype, corresponding, in most cases, to a proliferative arrest [1] . One of the emerging hallmarks of cancer is the unlocking of phenotypic plasticity, which allows cancer cells to escape the terminally differentiated state and change their phenotype. Thus, a cancer cell initially committed to the differentiation pathway of the normal cell from which it originated, can, during tumor progression, switch to an entirely different developmental program, acquiring tissue-specific traits that were not preordained by the normal cell from which it originated [2] . In this tumor plasticity, the tumor microenvironment (TME), its crosstalk with tumor cells and the mechanisms of epigenetic reprogramming are involved [3] . Hypoxia and nutrient deprivation constitute the main pressure on epigenome change to achieve rapid adaptation to the hostile situation [4] . The passage from a differentiated phenotype to a different one can take place in two alternative ways: by returning to an undifferentiated state to then re-diff","cbCairpUpIIPy42H","https://ap.wps.com/l/cbCairpUpIIPy42H","pdf",1986394,21,"English","# 1. Introduction\n# 2. Luminal to Basal-Like Transition (LBT) in Breast Cancer","[{\"question\":\"Why is tumor subtype classification important, and what challenge has emerged with next-generation sequencing?\",\"answer\":\"Subtype classification links phenotypes to differentiation pathways for diagnosis and targeted therapy. Next-generation sequencing shows cancer phenotypes are more heterogeneous and require continual updates to include additional subtypes.\"},{\"question\":\"How do tumor cells change subtype during disease progression and therapy response?\",\"answer\":\"Tumors can evolve dynamically and cancer cells may acquire the ability to transdifferentiate, switching subtype and adapting to the tumor microenvironment. These changes influence growth rate, invasiveness, treatment response, and overall clinical behavior.\"},{\"question\":\"Which cancers are examined to illustrate tissue plasticity-driven subtype switching?\",\"answer\":\"The article discusses four human cancers where tissue plasticity can cause a subtype switch: breast cancer, prostate cancer, glioblastoma, and pancreatic adenocarcinoma.\"}]","Subtype Transdifferentiation in Human Cancer - Tissue Plasticity and Tumor Progression | PDF",1790019350,53,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4b79eb1a0731a2d4e9be04c6e2512ee6.webp",983,1390,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a795009656bf78b583e7e29c2bf3b028.webp",982,1388,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6eec6e9bdf784a42b91d7d043cb5cbe5.webp",981,1387,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0d5f84b687fcbd06589d6b0025e1802c.webp",980,1385]